Cointime

Crinetics Pharmaceuticals

company

About

Crinetics is a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics.

  • 101 - 250

Highlights

Total Funding Amount
$108.90M
Funding Rounds
5
Investors
2
Investments
3

Details

Last Funding Type
Grant
Last Funding Money Raised
$3.20M
Industries
Biotechnology,Health Care,Pharmaceutical,Therapeutics
Founded date
Jan 1, 2008
Number Of Employee
101 - 250
Operating Status
Active

Crinetics Pharmaceuticals discovers and develops novel therapeutics targeting peptide hormone receptors for the treatment of endocrine-related diseases and cancers. Their programs are derived from internal discovery efforts and use objective hormonal biomarker endpoints for preclinical and clinical studies to reduce both the risk and cost to achieve meaningful clinical data. Crinetics is seeking motivated partners to help advance Their programs to become commercially successful products.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
5
$108.90M
Crinetics Pharmaceuticals has raised a total of $108.90M in funding over 2 rounds. Their latest funding was raised on Jun 21, 2018 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 21, 2018 Grant $3.20M 1 National Institutes of Health — Detail
Mar 13, 2018 Series B $63.50M 1 — — Detail
Nov 2, 2015 Series A $40M 1 — — Detail
Sep 3, 2013 Grant $2.20M 1 National Institutes of Health — Detail
Feb 7, 2009 Grant — 1 National Institutes of Health — Detail

Investments

Number of Investments
Number of Lead Investments
3
0
Crinetics Pharmaceuticals has made 3 investments. Their most recent investment was on Jul 6, 2021, when Meati raised $50M.
Date Company Name
Round Money Raised Industry Lead Investor
Jul 6, 2021 Meati
Series B $50M Consumer Goods —
Aug 21, 2020 Meati
Series A $28.20M Consumer Goods —
Apr 30, 2019 Small Door
Seed $3.50M Health Care —

Investors

Number of Lead Investors
Number of Investors
3
2
Crinetics Pharmaceuticals is funded by 2 investors. National Institutes of Health and Versant Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Yes Grant
Versant Ventures — Series B
Cointime
เนื้อหา
บริษัท